公开(公告)号：US07820687B2

公开(公告)日：2010-10-26

申请号：US12505383

申请日：2009-07-17

申请人： Jenifer Smith ,  Chris Semko ,  Ying-Zi Xu ,  Andrei W. Konradi

发明人： Jenifer Smith ,  Chris Semko ,  Ying-Zi Xu ,  Andrei W. Konradi

IPC分类号： A61K31/506 ,  A61P1/06 ,  A61P11/06 ,  A61P19/02 ,  A61P25/14 ,  A61P35/04 ,  A61P37/06 ,  C07D239/50 ,  C07D403/12

CPC分类号： C07D239/50

摘要： Disclosed are compounds, which bind VLA-4. Certain of these compounds also inhibit leukocyte adhesion and, in particular, leukocyte adhesion mediated by VLA-4. Such compounds are useful in the treatment of inflammatory diseases in a human or animal subject such as asthma, Alzheimer's disease, atherosclerosis, AIDS dementia, diabetes, inflammatory bowel disease, Crohn's disease, rheumatoid arthritis, tissue transplantation, tumor metastasis and myocardial ischemia. The compounds can also be administered for the treatment of inflammatory brain diseases such as multiple sclerosis.

摘要翻译： 公开了结合VLA-4的化合物。 这些化合物中的某些也抑制白细胞粘附，特别是由VLA-4介导的白细胞粘附。 此类化合物可用于治疗人或动物受试者如哮喘，阿尔茨海默氏病，动脉粥样硬化，艾滋病痴呆，糖尿病，炎性肠病，克罗恩病，类风湿性关节炎，组织移植，肿瘤转移和心肌缺血等炎性疾病。 化合物也可以用于治疗炎性脑疾病如多发性硬化症。

公开(公告)号：US20100261715A1

公开(公告)日：2010-10-14

申请号：US12759419

申请日：2010-04-13

申请人： Christopher Michael Semko ,  Ying-zi Xu ,  Frank Stappenbeck ,  Jenifer Lea Smith ,  Kassandra Inez Rossiter ,  Juri Y. Fukuda ,  Andrei W. Konradi

发明人： Christopher Michael Semko ,  Ying-zi Xu ,  Frank Stappenbeck ,  Jenifer Lea Smith ,  Kassandra Inez Rossiter ,  Juri Y. Fukuda ,  Andrei W. Konradi

IPC分类号： A61K31/541 ,  A61K31/506 ,  A61K31/5377 ,  A61P25/28 ,  A61P9/10 ,  A61P3/10 ,  A61P11/06 ,  A61P1/04 ,  A61P19/02 ,  A61P13/12 ,  A61P27/02 ,  A61P17/06 ,  A61P29/00 ,  A61P35/00

CPC分类号： C07D417/12 ,  C07D239/50 ,  C07D401/12 ,  C07D405/12 ,  C07D409/12 ,  C07D409/14

摘要： Disclosed are compounds which bind VLA-4. Certain of these compounds also inhibit leukocyte adhesion and, in particular, leukocyte adhesion mediated by VLA-4. Such compounds are useful in the treatment of inflammatory diseases in a mammalian patient, e.g., human, such as asthma, Alzheimer's disease, atherosclerosis, AIDS dementia, diabetes, inflammatory bowel disease, rheumatoid arthritis, tissue transplantation, tumor metastasis and myocardial ischemia. The compounds can also be administered for the treatment of inflammatory brain diseases such as multiple sclerosis.

公开(公告)号：US07763632B2

公开(公告)日：2010-07-27

申请号：US12352543

申请日：2009-01-12

申请人： Christopher Michael Semko ,  Ying-zi Xu ,  Frank Stappenbeck ,  Jenifer Lea Smith ,  Kassandra Inez Rossiter ,  Juri Y. Fukuda ,  Andrei W. Konradi

发明人： Christopher Michael Semko ,  Ying-zi Xu ,  Frank Stappenbeck ,  Jenifer Lea Smith ,  Kassandra Inez Rossiter ,  Juri Y. Fukuda ,  Andrei W. Konradi

IPC分类号： C07D239/50 ,  C07D401/12 ,  C07D401/14 ,  A61K31/505 ,  A61K31/506 ,  A61P29/00 ,  A61P19/02 ,  A61P11/06 ,  A61P25/28 ,  A61P1/00

CPC分类号： C07D403/02 ,  C07D239/50 ,  C07D401/12 ,  C07D405/12 ,  C07D409/12 ,  C07D417/12

摘要： Disclosed are compounds which bind VLA-4. Certain of these compounds also inhibit leukocyte adhesion and, in particular, leukocyte adhesion mediated by VLA-4. Such compounds are useful in the treatment of inflammatory diseases in a human or animal subject such as asthma, Alzheimer's disease, atherosclerosis, AIDS dementia, diabetes, inflammatory bowel disease, rheumatoid arthritis, tissue transplantation, tumor metastasis and myocardial ischemia. The compounds can also be administered for the treatment of inflammatory brain diseases such as multiple sclerosis.

摘要翻译： 公开了结合VLA-4的化合物。 这些化合物中的某些也抑制白细胞粘附，特别是由VLA-4介导的白细胞粘附。 这样的化合物可用于治疗人或动物受试者如哮喘，阿尔茨海默氏病，动脉粥样硬化，艾滋病痴呆，糖尿病，炎性肠病，类风湿性关节炎，组织移植，肿瘤转移和心肌缺血等炎性疾病。 化合物也可以用于治疗炎性脑疾病如多发性硬化症。

公开(公告)号：US07727996B2

公开(公告)日：2010-06-01

申请号：US11541205

申请日：2006-09-28

申请人： Christopher Michael Semko ,  Ying-zi Xu ,  Frank Stappenbeck ,  Jenifer Lea Smith ,  Kassandra Inez Rossiter ,  Juri Y. Fukuda ,  Andrei W. Konradi

发明人： Christopher Michael Semko ,  Ying-zi Xu ,  Frank Stappenbeck ,  Jenifer Lea Smith ,  Kassandra Inez Rossiter ,  Juri Y. Fukuda ,  Andrei W. Konradi

IPC分类号： C07D401/02 ,  A61K31/44

CPC分类号： C07D417/12 ,  C07D239/50 ,  C07D401/12 ,  C07D405/12 ,  C07D409/12 ,  C07D409/14

摘要： Disclosed are compounds which bind VLA-4. Certain of these compounds also inhibit leukocyte adhesion and, in particular, leukocyte adhesion mediated by VLA-4. Such compounds are useful in the treatment of inflammatory diseases in a mammalian patient, e.g., human, such as asthma, Alzheimer's disease, atherosclerosis, AIDS dementia, diabetes, inflammatory bowel disease, rheumatoid arthritis, tissue transplantation, tumor metastasis and myocardial ischemia. The compounds can also be administered for the treatment of inflammatory brain diseases such as multiple sclerosis.

摘要翻译： 公开了结合VLA-4的化合物。 这些化合物中的某些也抑制白细胞粘附，特别是由VLA-4介导的白细胞粘附。 这样的化合物可用于治疗哺乳动物患者，例如人类例如哮喘，阿尔茨海默氏病，动脉粥样硬化，艾滋病痴呆，糖尿病，炎性肠病，类风湿性关节炎，组织移植，肿瘤转移和心肌缺血等炎性疾病。 化合物也可以用于治疗炎性脑疾病如多发性硬化症。

公开(公告)号：US20100113434A1

公开(公告)日：2010-05-06

申请号：US12579828

申请日：2009-10-15

申请人： Christopher Michael Semko ,  Ying-zi Xu ,  Frank Stappenbeck ,  Jenifer Lea Smith ,  Kassandra Inez Rossiter ,  Juri Y. Fukuda ,  Andrei W. Konradi

发明人： Christopher Michael Semko ,  Ying-zi Xu ,  Frank Stappenbeck ,  Jenifer Lea Smith ,  Kassandra Inez Rossiter ,  Juri Y. Fukuda ,  Andrei W. Konradi

IPC分类号： A61K31/541 ,  A61K31/506 ,  A61K31/5377 ,  A61P37/00

CPC分类号： C07D417/12 ,  C07D239/50 ,  C07D401/12 ,  C07D405/12 ,  C07D409/12 ,  C07D409/14

摘要： Disclosed are compounds which bind VLA-4. Certain of these compounds also inhibit leukocyte adhesion and, in particular, leukocyte adhesion mediated by VLA-4. Such compounds are useful in the treatment of inflammatory diseases in a mammalian patient, e.g., human, such as asthma, Alzheimer's disease, atherosclerosis, AIDS dementia, diabetes, inflammatory bowel disease, rheumatoid arthritis, tissue transplantation, tumor metastasis and myocardial ischemia. The compounds can also be administered for the treatment of inflammatory brain diseases such as multiple sclerosis.

摘要翻译： 公开了结合VLA-4的化合物。 这些化合物中的某些也抑制白细胞粘附，特别是由VLA-4介导的白细胞粘附。 这样的化合物可用于治疗哺乳动物患者（例如人，例如哮喘，阿尔茨海默病，动脉粥样硬化，AIDS痴呆，糖尿病，炎性肠病，类风湿性关节炎，组织移植，肿瘤转移和心肌缺血）中的炎性疾病。 化合物也可以用于治疗炎性脑疾病如多发性硬化症。

公开(公告)号：US07579466B2

公开(公告)日：2009-08-25

申请号：US11679042

申请日：2007-02-26

申请人： Jenifer Smith ,  Christopher Semko ,  Ying-Zi Xu ,  Andrei W. Konradi

发明人： Jenifer Smith ,  Christopher Semko ,  Ying-Zi Xu ,  Andrei W. Konradi

IPC分类号： C07D239/50 ,  C07D403/12 ,  A61K31/506 ,  A61P19/02

CPC分类号： C07D239/50

摘要： Disclosed are compounds, which bind VLA-4. Certain of these compounds also inhibit leukocyte adhesion and, in particular, leukocyte adhesion mediated by VLA-4. Such compounds are useful in the treatment of inflammatory diseases in a human or animal subject such as asthma, Alzheimer's disease, atherosclerosis, AIDS dementia, diabetes, inflammatory bowel disease, Crohn's disease, rheumatoid arthritis, tissue transplantation, tumor metastasis and myocardial ischemia. The compounds can also be administered for the treatment of inflammatory brain diseases such as multiple sclerosis.

摘要翻译： 公开了结合VLA-4的化合物。 这些化合物中的某些也抑制白细胞粘附，特别是由VLA-4介导的白细胞粘附。 此类化合物可用于治疗人或动物受试者如哮喘，阿尔茨海默氏病，动脉粥样硬化，艾滋病痴呆，糖尿病，炎性肠病，克罗恩病，类风湿性关节炎，组织移植，肿瘤转移和心肌缺血等炎性疾病。 化合物也可以用于治疗炎性脑疾病如多发性硬化症。